Hepatitis C Virus-Related Hepatocellular Carcinoma in the Era of Direct-Acting Antiviral Agents

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

LIU XU; Gao Yanhang; Niu Junqi

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2018 | Volume:18 | Issue:6 Page(s): 0-0

Download Full-Text

View:

115

Download:

110

Cites:

Information Journal Paper

Title

Hepatitis C Virus-Related Hepatocellular Carcinoma in the Era of Direct-Acting Antiviral Agents

Author(s)

LIU XU | Gao Yanhang | Niu Junqi | Issue Writer Certificate

Keywords

Direct-Acting Antiviral Agents

Hepatocellular Carcinoma

Hepatitis C Virus

Review

Abstract

Context: The emergence of Direct-Acting Antiviral Agents (DAAs) with high sustained virological responses (SVR) is an epoch-making revolution. However, the value of antiviral agents in the field of hepatitis C-related Hepatocellular Carcinoma (HCC) is not clear. Further, the risk of tumor occurrence or recurrence following an antiviral regimen is not yet reached a consensus. Evidence Acquisition: All scientific evidence was collected through a systematic Review of studies discussing DAA regimen and hepatitis C-related HCC, in PubMed, EMBASE, andWeb of Science. The relevant articles were obtained and Reviewed carefully before working on the paper. Results: The current Review study aimed at discussing recent studies on hepatitis C-related HCC in the era of DAAs, including application of DAAs in the field of treatment of Hepatitis C Virus (HCV), efficacy of DAAs on HCV-associated HCC, and the effect of DAAs on occurrence and recurrence of HCC. Conclusions: It was shown that DAAs had a relatively poor therapeutic effect on HCV patients with HCC, based on the current studies. After analyzing the existing data, the conclusion cannot yet be reached that DAA treatment influences the risk of HCCin patients with HCV infection.

Cites

No record.

References

No record.

Cite

APA: Copy

LIU, XU, Gao, Yanhang, & Niu, Junqi. (2018). Hepatitis C Virus-Related Hepatocellular Carcinoma in the Era of Direct-Acting Antiviral Agents. HEPATITIS MONTHLY, 18(6), 0-0. SID. https://sid.ir/paper/764614/en

Vancouver: Copy

LIU XU, Gao Yanhang, Niu Junqi. Hepatitis C Virus-Related Hepatocellular Carcinoma in the Era of Direct-Acting Antiviral Agents. HEPATITIS MONTHLY[Internet]. 2018;18(6):0-0. Available from: https://sid.ir/paper/764614/en

IEEE: Copy

XU LIU, Yanhang Gao, and Junqi Niu, “Hepatitis C Virus-Related Hepatocellular Carcinoma in the Era of Direct-Acting Antiviral Agents,” HEPATITIS MONTHLY, vol. 18, no. 6, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/764614/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops